CANCER BUZZ PODCAST

Learn about the cultural and logistical barriers to end-of-life health equity and discover strategies that programs can implement to address palliative care earlier in the care continuum.

We discuss how the legacy of racism in American healthcare continues to affect today’s research, and share strategies for programs to communicate with underrepresented and marginalized populations.

Learn how the entire cancer care team can help in promoting safe oral anti-cancer medication adherence by bridging gaps in patient education, management, and monitoring.

Discover what steps cancer programs can take to build trust with patients from marginalized and underrepresented groups and ensure a more equitable and accessible healthcare environment.

Explore the barriers and challenges that LGBTQ+ patients with cancer face, and how cancer programs can make their care more inclusive.

On this episode of CANCER BUZZ, we discuss how healthcare providers and policymakers can work together to pave the future of telehealth beyond the current public health emergency.

Learn how the role of caregivers has changed during the pandemic, and how the cancer team can provide caregivers with guidance on taking care of patients with cancer.

We explore how patients are dealing with the "new normal,” and how oncology social workers, psychologists, and psychiatrists are working to help them through an unprecedented time.

Learn about the latest promising breakthroughs in immunotherapy, the challenges facing their widespread use, and what your cancer team needs to know about the future of cancer treatment.

We take a look at how the COVID-19 pandemic has impacted lung screenings across the country and how oncology teams are adapting their outreach and education to reach as many people as possible.

Learn about the role of the interdisciplinary cancer team in managing oral chemotherapy for patients with cancer, and discover how one cancer program has improved their workflow while keeping the patient at the center.

We mark the beginning of Lung Cancer Awareness Month by looking at the present landscape for the diagnosis and treatment of one of the most common cancers in the world.

Learn about effective tools to understand a patient’s values, preferences, goals, and priorities and discover strategies to help your patients ask important questions and make tough decisions.

Miami Cancer Institute shares their unique approach to helping patients with cancer understand why biosimilars may be their best—and most cost-effective—option for treatment.

On this mini-podcast, learn about the importance of reaching diverse populations with clinical trials where they live and how one clinical trial has prioritized community engagement.

Learn about the role of financial navigation in helping patients and providers understand the options available to patients in need of biomarker testing.

Learn how the Livestrong Cancer Institutes and Dell Medical School at the University of Texas at Austin are reaching out to young women in high school to generate interest in oncology.

Learn about dermatology’s role in the cancer care continuum and how cancer teams can better integrate dermatology into the immunotherapy care process.

We look at recent adaptations in oncology—and how some of these changes can actually make cancer care stronger moving forward.

We look at the latest data on the effects of COVID-19 on cancer practices and explore how you can adapt to changes in oncology business.

Learn how surgical oncology has been impacted by the coronavirus pandemic and how programs are adapting to fluctuations in staff availability and patient volume.

Learn about the ways cancer programs are working to reduce drug waste and curb the rising cost of cancer care.

Learn how some cancer programs are finding creative ways to engage patients and adapt screening programs during these difficult times.


Laura Holmes Haddad shares how her battle with breast cancer changed her perception of the resources available to younger adults with cancer, and what cancer programs can do to meet their needs.

Krista Nelson, ACCC President 2021-22, shares how Providence Cancer Institute has made staff resiliency and morale a priority during the COVID-19 pandemic.

Learn about Ochsner Cancer Center’s testing strategy for COVID-19 and how you can adapt their guidance when establishing your own testing protocols.

We explore how immunotherapy clinical trials have been affected by the pandemic and what cancer programs can do to safely and effectively administer clinical trials.

We discuss the personal protective equipment (PPE) shortages that cancer programs face, and how one program has taken creative steps to get what they need.